Tong Ren Tang Technologies Co. Ltd. (TGRNF)
Tong Ren Tang Technologies Co. Ltd.
No.20 Nansanhuan Zhonglu Road
Fengtai District
Beijing 100079
China
86 10 8763 2888
https://www.tongrentangkj.com
Sector(es): Healthcare
Industria: Drug Manufacturers - General
Empleados a tiempo completo: 4,101
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Jia Fu Chen | GM & Executive Director | 115.55k | N/D | 1969 |
| Ms. Zhi Mei Feng | Deputy GM & Executive Director | 138.21k | N/D | 1971 |
| Mr. Shu Bing Di | Chairman of the Board | N/D | N/D | 1975 |
| Mr. Guan Zhao Han | Deputy GM & General Legal Counsel | N/D | N/D | 1980 |
| Mr. Yijun Li | Joint Company Secretary | N/D | N/D | 1985 |
| Ms. Mei Yee Yung | Joint Company Secretary | N/D | N/D | N/D |
Descripción
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and internationally. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the wholesale and retail sale of Chinese medicines and healthcare products; technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; and internal and external surgery, medical examination, and traditional Chinese medicine department and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products; and offers medical services. Tong Ren Tang Technologies Co. Ltd. was founded in 1669 and is based in Beijing, the People's Republic of China.
Gestión corporativa
La calificación ISS Governance QuickScore de Tong Ren Tang Technologies Co. Ltd. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
